Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case report and review of the literature

CONCLUSIONS: The patient had an overall survival (OS) of 51 months, which is much higher than that reported in literature data. Unfortunately, the biology of Xp11.2 translocation RCC and its therapeutic management are still unclear.PMID:34696653 | DOI:10.1177/03008916211049275

Source: Tumori - October 26, 2021 Category: Cancer & Oncology Authors: Stefania Pipitone Maria Giuseppa Vitale Cinzia Baldessari Massimo Dominici Roberto Sabbatini Source Type: research